vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and CORE MOLDING TECHNOLOGIES INC (CMT). Click either name above to swap in a different company.

CORE MOLDING TECHNOLOGIES INC is the larger business by last-quarter revenue ($74.7M vs $39.8M, roughly 1.9× Carter Bankshares, Inc.). On growth, CORE MOLDING TECHNOLOGIES INC posted the faster year-over-year revenue change (19.5% vs 15.4%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $-2.9M). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs -2.2%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Core Molding Technologies, Inc. was founded in 1988 and now based in Columbus, Ohio. The company manufactures sheet molding compounds (SMC), and molds fiberglass reinforced plastics. It occupies over 1,000,000 square feet of manufacturing space and its main subsidiaries are in Matamoros, Mexico, Gaffney, South Carolina, and Cincinnati, Ohio. In 2011, Core Molding Technologies formed Core Specialty Composites, LLC.

CARE vs CMT — Head-to-Head

Bigger by revenue
CMT
CMT
1.9× larger
CMT
$74.7M
$39.8M
CARE
Growing faster (revenue YoY)
CMT
CMT
+4.1% gap
CMT
19.5%
15.4%
CARE
More free cash flow
CARE
CARE
$34.8M more FCF
CARE
$31.8M
$-2.9M
CMT
Faster 2-yr revenue CAGR
CARE
CARE
Annualised
CARE
9.1%
-2.2%
CMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
CMT
CMT
Revenue
$39.8M
$74.7M
Net Profit
Gross Margin
15.2%
Operating Margin
27.8%
4.8%
Net Margin
Revenue YoY
15.4%
19.5%
Net Profit YoY
EPS (diluted)
$0.38
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
CMT
CMT
Q4 25
$39.8M
$74.7M
Q3 25
$39.1M
$58.4M
Q2 25
$37.3M
$79.2M
Q1 25
$37.0M
$61.4M
Q4 24
$34.5M
$62.5M
Q3 24
$34.2M
$73.0M
Q2 24
$33.6M
$88.7M
Q1 24
$33.5M
$78.1M
Net Profit
CARE
CARE
CMT
CMT
Q4 25
Q3 25
$5.4M
$1.9M
Q2 25
$8.5M
$4.1M
Q1 25
$9.0M
$2.2M
Q4 24
Q3 24
$5.6M
$3.2M
Q2 24
$4.8M
$6.4M
Q1 24
$5.8M
$3.8M
Gross Margin
CARE
CARE
CMT
CMT
Q4 25
15.2%
Q3 25
17.4%
Q2 25
18.1%
Q1 25
19.2%
Q4 24
15.8%
Q3 24
16.9%
Q2 24
20.0%
Q1 24
17.0%
Operating Margin
CARE
CARE
CMT
CMT
Q4 25
27.8%
4.8%
Q3 25
18.3%
4.4%
Q2 25
28.5%
6.6%
Q1 25
30.1%
4.6%
Q4 24
31.0%
1.4%
Q3 24
20.5%
4.9%
Q2 24
17.6%
8.4%
Q1 24
21.6%
6.1%
Net Margin
CARE
CARE
CMT
CMT
Q4 25
Q3 25
13.9%
3.2%
Q2 25
22.8%
5.1%
Q1 25
24.2%
3.6%
Q4 24
Q3 24
16.4%
4.3%
Q2 24
14.3%
7.2%
Q1 24
17.4%
4.8%
EPS (diluted)
CARE
CARE
CMT
CMT
Q4 25
$0.38
$0.35
Q3 25
$0.24
$0.22
Q2 25
$0.37
$0.47
Q1 25
$0.39
$0.25
Q4 24
$0.36
$-0.01
Q3 24
$0.24
$0.36
Q2 24
$0.21
$0.73
Q1 24
$0.25
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
CMT
CMT
Cash + ST InvestmentsLiquidity on hand
$38.1M
Total DebtLower is stronger
$17.6M
Stockholders' EquityBook value
$419.7M
$158.2M
Total Assets
$4.9B
$228.1M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
CMT
CMT
Q4 25
$38.1M
Q3 25
$42.4M
Q2 25
$43.2M
Q1 25
$44.5M
Q4 24
$41.8M
Q3 24
$42.3M
Q2 24
$37.8M
Q1 24
$26.6M
Total Debt
CARE
CARE
CMT
CMT
Q4 25
$17.6M
Q3 25
$18.2M
Q2 25
$18.8M
Q1 25
$19.2M
Q4 24
$19.7M
Q3 24
$20.2M
Q2 24
$20.6M
Q1 24
$21.1M
Stockholders' Equity
CARE
CARE
CMT
CMT
Q4 25
$419.7M
$158.2M
Q3 25
$412.8M
$155.4M
Q2 25
$405.6M
$153.5M
Q1 25
$401.8M
$149.9M
Q4 24
$384.3M
$147.4M
Q3 24
$386.8M
$147.8M
Q2 24
$364.4M
$147.5M
Q1 24
$359.1M
$142.8M
Total Assets
CARE
CARE
CMT
CMT
Q4 25
$4.9B
$228.1M
Q3 25
$4.8B
$219.7M
Q2 25
$4.8B
$219.9M
Q1 25
$4.7B
$223.6M
Q4 24
$4.7B
$209.6M
Q3 24
$4.6B
$220.7M
Q2 24
$4.5B
$225.7M
Q1 24
$4.6B
$212.3M
Debt / Equity
CARE
CARE
CMT
CMT
Q4 25
0.11×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
Q2 24
0.14×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
CMT
CMT
Operating Cash FlowLast quarter
$39.9M
$5.0M
Free Cash FlowOCF − Capex
$31.8M
$-2.9M
FCF MarginFCF / Revenue
79.9%
-3.9%
Capex IntensityCapex / Revenue
20.2%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
CMT
CMT
Q4 25
$39.9M
$5.0M
Q3 25
$11.8M
$4.6M
Q2 25
$9.6M
$3.5M
Q1 25
$6.4M
$6.1M
Q4 24
$36.9M
$5.0M
Q3 24
$10.3M
$9.2M
Q2 24
$-2.5M
$15.9M
Q1 24
$17.6M
$5.1M
Free Cash Flow
CARE
CARE
CMT
CMT
Q4 25
$31.8M
$-2.9M
Q3 25
$10.3M
$-346.0K
Q2 25
$7.7M
$880.0K
Q1 25
$4.9M
$4.3M
Q4 24
$28.8M
$509.0K
Q3 24
$8.4M
$7.0M
Q2 24
$-4.3M
$13.0M
Q1 24
$16.3M
$3.2M
FCF Margin
CARE
CARE
CMT
CMT
Q4 25
79.9%
-3.9%
Q3 25
26.3%
-0.6%
Q2 25
20.6%
1.1%
Q1 25
13.1%
7.0%
Q4 24
83.5%
0.8%
Q3 24
24.6%
9.6%
Q2 24
-12.7%
14.6%
Q1 24
48.8%
4.1%
Capex Intensity
CARE
CARE
CMT
CMT
Q4 25
20.2%
10.7%
Q3 25
3.9%
8.4%
Q2 25
5.1%
3.3%
Q1 25
4.1%
2.9%
Q4 24
23.6%
7.2%
Q3 24
5.5%
3.1%
Q2 24
5.4%
3.3%
Q1 24
3.9%
2.4%
Cash Conversion
CARE
CARE
CMT
CMT
Q4 25
Q3 25
2.18×
2.44×
Q2 25
1.13×
0.86×
Q1 25
0.71×
2.79×
Q4 24
Q3 24
1.83×
2.92×
Q2 24
-0.51×
2.47×
Q1 24
3.03×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons